Novartis AG (NVS)

Profile

https://www.novartis.com

Novartis AG American Depositary Receipt is an ADR that enables U.S. investors to access shares of Novartis AG, a leading global healthcare company headquartered in Basel, Switzerland. This financial instrument represents ownership in the Swiss-based pharmaceutical giant, traded since May 11, 2000, on major U.S. exchanges with a 1:1 ratio to ordinary shares. Novartis AG focuses on innovative, research-driven pharmaceuticals across key therapeutic areas such as oncology, immunology, neuroscience, respiratory health, and cardiology. The company invests heavily in research and development to pioneer treatments and medical products that enhance patient care worldwide. It also contributes to generic and biosimilar markets, promoting more affordable healthcare solutions. With approximately 75,883 employees, Novartis AG maintains a significant global footprint, addressing needs in consumer, business, and government sectors. The ADR facilitates liquidity and accessibility, allowing international investors to participate in the pharmaceutical industry's advancements without direct engagement in foreign markets.